UCSF has a long history of pioneering biomedical research and a bold vision for advancing science and seeking new ways to improve health care delivery nationwide. But, what does that actually mean in the near future and beyond?
This new series, part of the popular Mini Medical School for the Public, takes you inside the work of UCSF scientists to learn what the next decade may bring to the world of medicine. Hailing from a wide spectrum of disciplines, each explores a different topic that has the potential to impact the future of healthcare.
UCSF was the only medical school to be ranked in the top five in the nation in both research and primary care by US News and World Report, ranking fifth in biomedical research and third in primary care education. UCSF was also the only medical school ranked in the top five in all eight of the specialty areas covered by the survey in 2019.
Browse more programs in Next: UCSF Scientists Outline What’s To Come .
Every 65 seconds, someone in the United States develops Alzheimer’s disease. What can be done to stem the tide of this devastating disease? Researchers are looking to our genes. “One of the goals of genetics is to try and come up with as strong a set of predictors as is possible. This has influenced the way in which more recent genetic research has been done,” says Douglas R. Galasko, MD. On this episode of “On Our Mind,” Dr. Galasko shares the different types of genetic influences on people’s risk of developing Alzheimer’s disease. He explains how these genes are being studied and what being a carrier of Alzheimer’s associated genes means.
For more information on Alzheimer’s disease, visit our archive.
Watch What Role Do Genetics Play in Alzheimer’s? – On Our Mind
Continuing our in-depth look at Alzheimer’s disease, On Our Mind examines the patient experience as well as the impact of the disease on families and communities. Learn more with our newest installments:
Neuroimaging Advances for Alzheimer’s Disease
What insights can new imaging techniques give us not only to the biology of the disease but the efficacy of new therapies?
Caregiver Concerns: Wandering, Home Safety and More
Six in ten people with dementia will wander. Learn how to create a home environment that facilitates safety.
Residential Care and Alzheimer’s Disease
Making the residential care decision can feel overwhleming. Learn how residential care has changed and the impact of care with dignity.
The Brain Channel’s flagship series On Our Mind takes a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.
Watch all of the Alzheimer’s Disease programs.
An estimated 5 million Americans have Alzheimer’s disease and that number will continue to rise. The impact will be felt not just in the homes of the diagnosed but by their caregivers, their loved ones, their communities, and beyond.
The Brain Channel’s flagship series On Our Mind is endeavoring in the next few months to take a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.
Agenda: Alzheimer’s Disease Cure and Care
There are more than 5 million Americans living with Alzheimer’s disease. San Diego County Supervisor Dianne Jacob joins William Mobley, MD, PhD to discuss how we can better manage this disease from a public policy standpoint.
Stem Cells and Alzheimer’s Disease
Can stem cells be a weapon in the fight against Alzheimer’s disease? Larry Goldstein, PhD director the the UC San Diego Stem Cell Program, joins William Mobley, MD, PhD to discuss how stem cells work and what possibilities they may unlock.
The Anatomy of Memory
How do we create and store memories? Larry Squire PhD joins William Mobley MD, PhD to dissect these processes and how we might use this knowledge to aid in the fight against Alzheimer’s disease.
The Role of Synapses in Memory
Roberto Malinow, MD, PhD joins William Mobley MD, PhD to discuss his recent study where memories were not only erased but restored in rats. Learn how findings of this study could lead to breakthroughs in the treatment of Alzheimer’s disease.
Stay tuned to the Brain Channel for new installments in this informative series.